JCO -Abstract TPS3157: Phase 1/2 study of PRO1184, a novel folate receptor alpha-directed antibody-drug conjugate, in patients wit......
2023-06-01
Cancer Res -Abstract 2637: Novel folate receptor alpha-directed antibody-drug conjugate PRO1184 demonstrates broad antitumor activ......
2023-04-04
Cancer Res -Abstract 1759: PRO1160, a novel CD70-directed antibody-drug conjugate, demonstrates robust anti-tumor activity in mous......
2022-06-15
Cancer Res -Abstract 1758: The preclinical pharmacology of PRO1102, a novel exatecan-based HER2-directed antibody-drug conjugate w......
Cancer Res -Abstract 1405: Novel ADC platform delivers promising in vivo activity and safety
Cancer Res -Abstract 1085: PRO1184, a novel folate receptor alpha-directed antibody-drug conjugate, demonstrates robust anti-tumor......
Mol Cancer Ther- Abstract P196: Novel hydrophilic drug linkers enable exatecan-based antibody-drug conjugates with promising physi......
2021-12-01
